Dr. Reddy's Loses Bid To Invalidate Teva Patents
A district judge has allowed Teva Pharmaceutical Industries Ltd. to proceed with its lawsuit to bar Dr. Reddy's Laboratories Inc. from marketing a generic version of GlaxoSmithKline Inc.'s congestive heart failure...To view the full article, register now.
Already a subscriber? Click here to view full article